All News
Filter News
Found 21,829 articles
-
SALAs Offer No Edge Over Other NSAIDs in Reducing Alzheimer's Risk, Johns Hopkins University Bloomberg School of Public Health Finds
5/29/2008
-
Protein Fibrils As Alternative Plastics? Amyloids Are Not Just Pathological Agents, They Are Interesting Nanomaterials, University of Tel Aviv Researchers Find
5/29/2008
-
Galantos Pharma Receives Research Grant
5/28/2008
-
Provista Life Sciences LLC Selected to Represent Phoenix at 2008 Biotechnology Industry Organization (BIO) International Convention
5/28/2008
-
Myriad Genetics, Inc. Selects H. Lundbeck A/S as European Partner for Flurizan; Myriad Receives $100 Million Upfront for European Rights to Alzheimers Disease Drug Candidate
5/22/2008
-
Aspect Medical Systems, Inc. to Discuss Sales Force Expansion Plan on May 29, 2008
5/22/2008
-
PRANA Biotechnology Announces $7 Million Placement to Fund Research Programs
5/21/2008
-
Ironwood Pharmaceuticals and Forest Laboratories, Inc. Announce Presentation of Linaclotide Phase 2b Results; Linaclotide Meets Primary Endpoint
5/21/2008
-
Forest Laboratories, Inc. and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
5/21/2008
-
EPIX Pharmaceuticals, Inc. to Participate in Panel Session at the First International Neuron to Synapse 2008 Meeting
5/21/2008
-
Vaccine Triggers Immune Response, Prevents Alzheimer's In Mice, University of Rochester Study
5/20/2008
-
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
5/20/2008
-
Applied NeuroSolutions, Inc. Q1 2008 Alzheimer's Disease Diagnostic Development Programs Update
5/20/2008
-
Cortex Pharmaceuticals, Inc. Announces Mark Varney to Become President and Chief Executive Officer
5/19/2008
-
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
5/19/2008
-
Families Shed Light On Likely Causative Gene For Alzheimer's, Medical College of Georgia and Charlie Norwood Veterans Affairs Medical Center Study
5/15/2008
-
Fate Therapeutics Announces New CEO
5/15/2008
-
Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
5/15/2008
-
Allon Therapeutics, Inc. Releases First Quarter Operating Results
5/15/2008
-
Transition Therapeutics Inc. Announces Third Quarter Fiscal 2008 Financial Results
5/15/2008